Pharmafile Logo

Value-Based Cancer Care

- PMLiVE

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

Initial guidance says drug is too costly but encourages further data

- PMLiVE

Novo Nordisk gets MACE prevention claim for Ozempic in US

Key product for the future growth of Novo's diabetes franchise

- PMLiVE

NantKwest rockets on promising pancreatic cancer data

One patient demonstrated a complete response following treatment

- PMLiVE

Integrating electronic health records into clinical trials

How organisations are working to realise the research potential of EHRs

- PMLiVE

Lucid Group expands its presence in the north-west with six new hires

Healthcare 21, a Lucid Group company, continues to strengthen its editorial and medical writing team with six new additions to its Macclesfield office.Rosanna Farrell joins HealthCare 21 as a Senior...

Lucid Group Communications Limited

- PMLiVE

How 2019 ignited my passion for insights

Stacey East, Insights Manager, Origins, shares her learnings from the Pharma Market Research Conference

Bedrock Healthcare Communications

Bristol Myers Squibb logo

FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC

A verdict is expected to be delivered by 15 May

- PMLiVE

Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer

If approved would become first targeted therapy for tumour type

- PMLiVE

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly paid $25m upfront on top of a $15m equity investment

- PMLiVE

Christie Anbar appointed global healthcare lead at Ruder Finn

Anbar will oversee the agency's entire healthcare business

- PMLiVE

RFA strengthens team with a host of hires and promotions

New hires coincide with continued growth

- PMLiVE

Keeping up the fight against HIV and using the lessons to tackle other threats

Danny Buckland interviews Gilead’s Mike Elliott

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links